Digital Transformation Opportunities Corp.
DTOC
NASDAQ Capital Market25.97
USD
+12.27
- -
CIK
0001839998
ISIN
US25401K1079
CUSIP
25401K107
Return %
Stock
S&P500
1Y
162.59
24.99
3Y
170.52
70.19
5Y
170.52
77.45
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Kevin Nazemi
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 10485 NE 6th Street Bellevue WA United States of America 98004
- IPO Date
- May 5, 2021
- CIK
- 0001839998
- Website
- dtocorp.com
- Similar Companies
- Business
- Digital Transformation Opportunities Corp. (DTOC; NASDAQ:DTOC) is a blank check company, or special purpose acquisition company (SPAC), formed in 2020 and headquartered in Bellevue, Washington, that seeks to effect mergers, share exchanges, asset acquisitions, or similar business combinations primarily with targets in the healthcare industry leveraging digital technologies. The company, which completed its initial public offering in 2021, currently holds no substantial operations or products but maintains cash raised from its IPO in trust pending a de-SPAC transaction; it focuses on innovative businesses in areas such as cloud computing, artificial intelligence, and healthcare delivery systems. Geographically, DTOC operates from the United States with a target focus on domestic healthcare opportunities. In 2022, DTOC announced a proposed business combination with American Oncology Network (AON), a physician-led network providing oncology services across 19 states, valuing the pro forma entity at approximately $497 million enterprise value with up to $100 million in PIPE financing; the deal, initially targeted for closure in early 2023, included sponsor earnouts and lock-up provisions but has not closed as of late 2025, prompting multiple deadline extensions including in July 2023. The company received a small funding infusion of $0.15 million in March 2023 amid ongoing merger pursuits. No further acquisitions, partnerships, new product launches, or strategic shifts have materialized in 2024 or 2025, leaving DTOC in a pre-combination phase with its charter deadline potentially extended beyond original terms.
Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer
American Oncology Network, a Rapidly Growing Network of Community-Based Oncology Practices, to go Public through Business Combination with Digital Transformation Opportunities Corp.
Digital Transformation Opportunities Corp. Announces the Separate Trading of Its Class a Common Stock and Warrants, Commencing on April 30, 2021